News

Senator Blunt, Rep. DeLauro, and developers of child-friendly TB medicines honored with GHTC Innovating for Impact Awards

GHTC yesterday honored Senator Roy Blunt (R-MO) and Congresswoman Rosa DeLauro (D-CT) at its second annual Innovating for Impact Awards, which celebrates US policymakers and partnerships driving progress in global health innovation. GHTC also recognized the partnership that developed and introduced improved child-friendly tuberculosis (TB) medicines, making these transformative treatments available to children in need worldwide.

Learn More
GHTC opens call for nominations for 2018 Innovating for Impact Awards

GHTC has opened nominations for its 2018 Innovating for Impact Awards. Now in its second year, this initiative celebrates the partnerships and policymakers driving global health innovation. The nomination deadline is August 17, 2018.

Learn More
PATH/Dan Change
GHTC welcomes launch of first-ever WHO list of essential diagnostic tests

GHTC welcomes the publication today by the World Health Organization (WHO) of its first Essential Diagnostics List, a critical new tool to help guide governments on the vital diagnostic tests that should be made available through health care systems.

Learn More
As White House seeks big cuts in global health research, new state-by-state analysis shows US government investment brings jobs, health security to states while saving millions of lives worldwide

The Trump Administration’s proposal to slash funding to fight global health threats like malaria, Ebola, and HIV/AIDS could cost states thousands of jobs and millions of dollars in economic investment and put the health of residents at risk, according to a new state-by-state analysis released today on Capitol Hill by the Global Health Technologies Coalition.

Learn More
GHTC announces changes to membership structure

GHTC announced today changes to its membership structure to better serve its existing membership and engage a broader group of global health R&D stakeholders in its advocacy activities. Effective now, GHTC will begin offering three types of membership.

Learn More
Flickr/Helena Peixoto
GHTC statement on the President’s FY 2019 budget

The United States has long led the world in developing vaccines, drugs, diagnostics, and other technologies for neglected diseases and conditions that affect the world’s most vulnerable people, and the President’s budget proposal threatens to undermine this scientific and humanitarian legacy.

Learn More
PATH/Patrick McKern
GHTC welcomes House passage of the Global Health Innovation Act

GHTC welcomes yesterday’s passage by the US House of Representatives of the Global Health Innovation Act (H.R. 1660), a bipartisan bill that will strengthen efforts by the US Agency for International Development (USAID) to develop lifesaving drugs, vaccines, and other health technologies for people in need around the world.

Learn More
GHTC honors Senator Coons, Congressman Cole, and the dapivirine microbicide ring with Innovating for Impact Awards

Esteemed leaders from across the US government, industry, and the global health and medical research communities gathered at the Newseum in Washington, DC yesterday for GHTC’s Innovating for Impact Awards to celebrate US commitment to global health R&D and recognize Senator Chris Coons (D-DE) and Congressman Tom Cole (R-OK) for their congressional leadership on this issue. GHTC also honored the partnership that developed the dapivirine microbicide ring—a woman-centered HIV prevention tool—for its efforts to advance this groundbreaking new technology.

Learn More

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide